Pfizer Inc [PFE] stock is trading at $24.48, up 0.74%. An important factor to consider is whether the stock is rising or falling in short-term value. The PFE shares have gain 4.66% over the last week, with a monthly amount glided 6.02%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pfizer Inc [NYSE: PFE] stock has seen the most recent analyst activity on April 22, 2025, when Cantor Fitzgerald initiated its Neutral rating and assigned the stock a price target of $24. On November 15, 2024, Wolfe Research initiated with a Underperform rating and assigned a price target of $25 on the stock. Bernstein initiated its recommendation with a Mkt Perform and recommended $32 as its price target on October 17, 2024. Daiwa Securities upgraded its rating to Outperform for this stock on August 07, 2024. In a note dated March 22, 2024, Argus downgraded an Hold rating on this stock.
Pfizer Inc [PFE] stock has fluctuated between $20.92 and $31.54 over the past year. Currently, Wall Street analysts expect the stock to reach $28 within the next 12 months. Pfizer Inc [NYSE: PFE] shares were valued at $24.48 at the most recent close of the market. An investor can expect a potential return of 14.38% based on the average PFE price forecast.
Analyzing the PFE fundamentals
Pfizer Inc [NYSE:PFE] reported sales of 62.46B for the trailing twelve months, which represents a drop of -7.82%. Gross Profit Margin for this corporation currently stands at 0.67% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.09 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.68.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.30 points at the first support level, and at 24.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.67, and for the 2nd resistance point, it is at 24.87.
Ratios To Look Out For
For context, Pfizer Inc’s Current Ratio is 1.26. On the other hand, the Quick Ratio is 0.96, and the Cash Ratio is 0.04. Considering the valuation of this stock, the price to sales ratio is 2.23, the price to book ratio is 1.54 and price to earnings (TTM) ratio is 17.74.
Transactions by insiders
Recent insider trading involved Dolsten Mikael, Former Officer, that happened on May 23 ’25 when 59781.0 shares were purchased. Former Officer, Dolsten Mikael completed a deal on May 05 ’25 to buy 55000.0 shares. Meanwhile, SVP & Controller DAMICO JENNIFER B. sold 2500.0 shares on Mar 04 ’25.
